Antonin de Fougerolles is the CEO of Evox Therapeutics and a Venture Partner at Ascension Ventures with over 20 years’ experience in the pharmaceutical and biotechnology industry.
He has a background in developing transformative therapeutic drug platforms in the nucleic acid and biologics space. His expertise has led to the progression of multiple assets through clinical trials.